InvestorsHub Logo

buzzabby

10/22/17 10:34 AM

#6348 RE: Nan Doe #6343

Wow this is going to be huge.

This video really ties things together and shows the value. Patent pending one of a kind. Look at the efficiency this will bring for medical providers and insurance companies. Not to mention the data that can be collected which would be very valuable and desirable to Pharma on the drugs. Very well thought out platform.

Now that we have seen the platform its a matter of implementation. Adoption by patients and by the medical professional monitoring be that Dr's or Pharmacist will be important. This Benefits insurance companies in a huge way by fixing treatment before it is to late. I believe this will change the game in Diabetes care. Big Pharma will benefit from regular testing resulting in higher sales of products. Patients will get really time feedback and adhere to their care plans. Dr's or Pharmacist get easy to use alerts to manage patients care plans.

Can anyone see any bugs or flaws? I am trying to pick it apart. What would be the downside. It looks very innovative to me even more so after watching the new video

Obviously different laws in different regions apply with who can prescribe and monitor and laws in this regard are also changing quickly. This platform appears to move in the same curve as the laws.

Who will they co market this with? There is a lot of groups/companies that could benefit but what would make the most sense? What is the cost of the platform and how will reimbursements work? Lots of questions now that I have seen the total package. The ALRT strategy is taking shape quickly since Clearance.